Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
ANXA3 encodes a member of the annexin family. Zusätzlich bieten wir Ihnen Annexin A3 Proteine (27) und Annexin A3 Kits (16) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 154 products:
Horse (Equine) Polyclonal Annexin A3 Primary Antibody für IHC, WB - ABIN2774839
Sekar, Sambandam, Grizzle, McDonald: Dissociation of cyclic inositol phosphohydrolase activity from annexin III. in The Journal of biological chemistry 1996
Show all 5 Pubmed References
Human Monoclonal Annexin A3 Primary Antibody für IHC, WB - ABIN2453953
Pan, Pan, Weng, Zhao, Zhang, Wang, Lv, Jiang, Zheng, Xia: Annexin A3 promotes tumorigenesis and resistance to chemotherapy in hepatocellular carcinoma. in Molecular carcinogenesis 2015
Show all 2 Pubmed References
Human Monoclonal Annexin A3 Primary Antibody für RNAi, ELISA - ABIN559876
Cao, Ye, Zhang, Zhu, Wang, Yao: A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer. in The Prostate 2011
Show all 2 Pubmed References
Human Polyclonal Annexin A3 Primary Antibody für IP, WB - ABIN1327266
Meadows, Cleaver: Annexin A3 Regulates Early Blood Vessel Formation. in PLoS ONE 2015
Human Polyclonal Annexin A3 Primary Antibody für ICC, IF - ABIN4280815
Dinets, Pernemalm, Kjellin, Sviatoha, Sofiadis, Juhlin, Zedenius, Larsson, Lehtiö, Höög: Differential protein expression profiles of cyst fluid from papillary thyroid carcinoma and benign thyroid lesions. in PLoS ONE 2015
Annexin A3 regulates early blood vessel formation.
ANXA3 role in the proliferation and invasion of breast cancer cells.
Results identified potential variant in ANXA3 gene [chr4, c.C820T(p.R274*)] in a large family with an unknown equinus deformity, which could lead to a three-dimensional conformational change.
Anxa3 knockdown inhibited the growth, migration, invasion, and metastasis of lung adenocarcinoma.
These results suggest that the iEA index or a combination of polymorphisms in EGFR (zeige EGFR Antikörper) and ANXA3 may serve as predictive factors of drug response, and therefore could be useful for optimal selection of chemotherapy regimens.
ANX (zeige ANXA5 Antikörper) A3 has roles as a mammary biomarker, regulator and therapeutic target in breast cancer
Our results suggest that ANXA3 can serve as a novel diagnostic biomarker and that the inhibition of ANXA3 may be a viable therapeutic option for the treatment of CD133+ liver-CSC-driven HCC (zeige FAM126A Antikörper).
Findings reveal that ANXA3 might play an important role in hepatocellular carcinoma progression and chemoresistance.
findings suggest that ANXA3 plays a role in HCC (zeige FAM126A Antikörper) CSC/CIC (zeige CIC Antikörper) maintenance, and that ANXA3 may represent a potential CSC/CIC (zeige CIC Antikörper)-specific therapeutic target for improving the treatment of HCC (zeige FAM126A Antikörper).
Two different antigenic variants of ANXA3 are present in post-DRE (zeige SUFUH Antikörper) urines and their clinical significance for diagnosis of prostate cancer should be further investigated.
Urinary calreticulin (zeige CALR Antikörper), annexin A2 (zeige ANXA2 Antikörper), and annexin A3 are very likely a panel of biomarkers with potential value for upper tract urothelial carcinoma diagnosis.
data suggest that annexin A3 is a negative regulator of adipocyte differentiation
AnxA3 is not only endogenously expressed in mouse cortical neurons but more importantly, it is transcriptionally up-regulated with onset of lactacystin-mediated death in murine primary cortical neurons.
This gene encodes a member of the annexin family. Members of this calcium-dependent phospholipid-binding protein family play a role in the regulation of cellular growth and in signal transduction pathways. This protein functions in the inhibition of phopholipase A2 and cleavage of inositol 1,2-cyclic phosphate to form inositol 1-phosphate. This protein may also play a role in anti-coagulation.
, Annexin A3
, annexin A3-like
, annexin a3
, 35-alpha calcimedin
, Annexin III (lipocortin III)
, annexin III (lipocortin III, 1,2-cyclic-inositol-phosphate phosphodiesterase, placental anticoagulant protein III, calcimedin 35-alpha)
, calcimedin 35-alpha
, inositol 1,2-cyclic phosphate 2-phosphohydrolase
, lipocortin III
, placental anticoagulant protein III
, annexin III
, Annexin III (Lipocortin III)